Aegis Ventures

Loyal, a platform helping health systems and hospitals connect with patients, and AI-enabled pathology company PathAI adds new leadership.

The startup plans to use AI-backed retinal imaging to find early signs of disease based on tech from Australian company Eyetelligence.

Aegis Ventures' John Beadle discusses partnerships between venture capital firms and health systems, the move from direct-to-consumer to business-to-business models and what digital health investment could look like next year.

Upliv is expected to receive $8.4 million in seed funding through the end of 2023.

As part of the deal, Aegis Ventures will pour $100 million in seed-stage funding into the effort.